SLC6A3 and attention deficit-hyperactivity disorder: In the meantime, DAT polymorphisms that trigger anomalous DA uptake [7,8] may be associated with neuropsychiatric disorders, including bipolar disorder, autistic spectrum disorders (ASD), or attention-deficit/hyperactivity disorder (ADHD) [8,9,10].